Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 280

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Progression of Liver Fibrosis in Women Infected With Hepatitis C: Long–Term Benefit of Estrogen Exposure

Open access
Di Martino, Vincent, Lebray, Pascal, Myers, Robert P., Pannier, Emmanuelle, Paradis, Valérie, Charlotte, Frédéric, Moussalli, Joseph, Thabut, Dominique, Buffet, Catherine, Poynard, Thierry·2004·Hepatology

Abstract

Female sex is a protective factor for the progression of fibrosis in patients with chronic hepatitis C virus (HCV) infection. Experimental data suggest that estrogens may have an antifibrotic effect. The objective of this study was to evaluate the influence of past pregnancies, oral contraceptives, menopause, and hormone replacement therapy (HRT) on liver fibrosis progression in HCV–infected women. Four hundred seventy–two HCV–infected women received a survey regarding prior pregnancies, menopause, and the use of oral contraceptives and HRT. The impact of these variables on liver fibrosis and its progression were evaluated using multivariate analyses considering all putative confounding factors. Two hundred one women completed the survey (43% response rate), 157 of whom had an estimated date of HCV infection (96 postmenopausal women, 96 women with previous pregnancies, and 105 women with past use of oral contraceptives). Through multivariate analyses, the estimated rate of fibrosis progression was higher in postmenopausal ( P < .05) and nulliparous ( P = .02) women and was associated with greater histological activity ( P < .001). Prior use of oral contraceptives had no significant influence. Among postmenopausal women, the estimated rate of fibrosis progression (±SE) was lower in women who received HRT compared with untreated patients (0.099 ± 0.016 vs. 0.133 ± 0.006 METAVIR units/yr; P = .02) and was similar to that of premenopausal women (0.093 ± 0.012 METAVIR units/yr; P value not significant). In conclusion , menopause appears to be associated with accelerated liver fibrosis progression in HCV–infected women, an effect that may be prevented by HRT. Pregnancies may have a beneficial impact on the long–term progression of liver fibrosis. (Hepatology 2004;40:1426-1433.)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.20463

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 280

Metadata

Authors
Di Martino, V., Lebray, P., Myers, R. P., Pannier, E., Paradis, V., Charlotte, F., Moussalli, J., Thabut, D., Buffet, C., & Poynard, T.
Venue
Hepatology
Published
2004-12
Volume
40
Issue
6
Pages
1426-1433
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2027154705
Cited by
280
References
24
FWCI
3.71
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Progression of Liver Fibrosis in Women Infected With Hepatitis C: Long–Term Benefit of Estrogen Exposure. https://app.cochat.ai/papers/10.1002/hep.20463
The paper
Di Martino, V., Lebray, P., Myers, R. P., Pannier, E., Paradis, V., Charlotte, F., Moussalli, J., Thabut, D., Buffet, C., & Poynard, T. (2004). Progression of Liver Fibrosis in Women Infected With Hepatitis C: Long–Term Benefit of Estrogen Exposure. Hepatology. https://doi.org/10.1002/hep.20463

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.